2022
DOI: 10.1002/wjo2.80
|View full text |Cite
|
Sign up to set email alerts
|

A comprehensive review and characterization of nasopharyngeal carcinoma clinical trials

Abstract: Objective: Although standard of care for primary nasopharyngeal carcinoma (NPC) is chemoradiotherapy, there remains no consensus on management of recurrent or metastatic disease. We characterized recent clinical trials on NPC to assess trends in NPC treatment and establish promising areas for future research.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 20 publications
0
0
0
Order By: Relevance